SEC Company Response from Predictive Oncology Inc. (AGPU) (CIK 0001446159) (AGPU) — Dec 20, 2017
Predictive Oncology Inc. (AGPU) (CIK 0001446159)
Date: Dec. 20, 2017 · CIK: 0001446159 · Accession: 0001171843-17-007763
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-221966
Letter
Skyline Medical Inc.
2915 Commers Drive, Suite 900
Eagan, Minnesota 55121
December 20, 2017
BY EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Ms. Heather Percival
Re: Skyline Medical Inc.
Registration Statement on Form S-3
File No. 333-221966
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Skyline Medical Inc., a Delaware corporation (the “Registrant”), hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), be accelerated so that it will be declared effective at 3:00 p.m. Eastern time on December 21, 2017, or as soon thereafter as practicable.
Very truly yours,
Skyline Medical Inc.
Show Raw Text
CORRESP
1
filename1.htm
Skyline Medical Inc.
2915 Commers Drive, Suite 900
Eagan, Minnesota 55121
December 20, 2017
BY EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Ms. Heather Percival
Re:
Skyline Medical Inc.
Registration Statement on Form S-3
File No. 333-221966
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 of the General Rules and Regulations
under the Securities Act of 1933, as amended, Skyline Medical Inc., a Delaware corporation (the “Registrant”),
hereby requests that the effectiveness of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”),
be accelerated so that it will be declared effective at 3:00 p.m. Eastern time on December 21, 2017, or as soon thereafter as practicable.
Very truly yours,
Skyline Medical Inc.
By:
/s/ Bob Myers
Name: Bob Myers
Title: Chief Financial Officer